Binge eating disorder
Pro Research Analysisby 
Searched over 200M research papers
Understanding Binge Eating Disorder: Diagnosis, Prevalence, and Treatment
Introduction to Binge Eating Disorder (BED)
Binge Eating Disorder (BED) is the most common eating disorder, affecting approximately 3% of U.S. adults in their lifetime. It is characterized by recurrent episodes of binge eating, where individuals consume large amounts of food in a short period while feeling a lack of control . BED is more prevalent in women (3.5%) than men (2.0%) and is particularly common among obese individuals, with prevalence rates ranging from 5% to 30% .
Diagnostic Criteria and Epidemiology
BED was officially recognized as a distinct eating disorder in the DSM-5 in 2013, which lowered the diagnostic threshold for frequency and duration of symptoms 12. The disorder is marked by episodes of eating until uncomfortably full, eating when not physically hungry, eating alone due to embarrassment, and feelings of depression or guilt post-binge . The global prevalence of BED is estimated at 0.9%, with higher rates in women (1.4%) compared to men (0.4%) .
Psychological and Physical Implications
Individuals with BED often experience significant psychological distress, including major depressive disorders, anxiety, and impaired social functioning 12. Physically, BED is associated with obesity, type 2 diabetes, metabolic syndrome, and chronic pain . The disorder also complicates obesity treatments, such as bariatric surgery, due to nonadherence to dietary recommendations .
Treatment Approaches
Psychological Treatments
Cognitive Behavioral Therapy (CBT) is the cornerstone of BED treatment, recommended by both the American Psychiatric Association (APA) and the National Institute for Health and Care Excellence (NICE) 12. CBT aims to reduce binge-eating frequency and improve psychological well-being. Other effective psychotherapies include interpersonal therapy (IPT) and dialectical behavior therapy (DBT) .
Pharmacological Treatments
Medications such as selective serotonin reuptake inhibitors (SSRIs), lisdexamfetamine, and anticonvulsants have shown efficacy in reducing binge-eating episodes 110. However, the long-term effectiveness of pharmacological treatments requires further research due to limited sample sizes and short follow-up periods .
Combined and Sequential Treatments
Combining psychological and pharmacological treatments does not significantly enhance outcomes compared to individual treatments. A stepped-care approach, starting with guided self-help and progressing to more intensive treatments as needed, is recommended 210. This approach allows for tailored interventions based on individual patient responses.
Conclusion
Binge Eating Disorder is a prevalent and debilitating condition with significant psychological and physical health implications. Effective management requires a multidisciplinary approach, incorporating both psychological and pharmacological treatments. Continued research is essential to refine treatment strategies and improve long-term outcomes for individuals with BED.
Sources and full results
Most relevant research papers on this topic